AI assistant
Sending…
RESMED INC — Director's Dealing 2011
Jan 5, 2011
30071_dirs_2011-01-05_dfb08060-2fe8-426a-84dc-2e24f27075b7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-10-04
Reporting Person: FARRELL PETER C (Director, Executive Chairman)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-11-11 | ResMed Common Stock Options | $33.70 | A | 100000 | Acquired | 2017-11-11 | ResMed Common Stock (100000) | Direct |
Footnotes
F1: Represents first date 1/4 of the options become exercisable. thereafter, options will continue to vest 1/4 annually until fully vested.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29